商业与经济

Novo says Wegovy injection lowers BMI and obesity rates in children in trial

来源: Business News · 发布于

Novo says Wegovy injection lowers BMI and obesity rates in children in trial
来源: Business News

Wegovy is already approved to treat obesity in children ages 12 and older, but there are currently no approved medications for those under 12.

Wegovy is already approved to treat obesity in children ages 12 and older, but there are currently no approved medications for those under 12.

阅读原文来源